has served as a consultant for AbbVie, Astellas, AstraZeneca, Boehringer Ingelheim, Fresenius, Gilead, Janssen, Merck, Mundipharma, Mitsubishi Tanabe, and Retrophin and has received grant support from AbbVie, AstraZeneca, Boehringer Ingelheim, and Janssen
20 In adolescents with obesity, semaglutide 2.4 mg once weekly resulted in similar weight loss to that seen in adults (16.1% mean change in body mass index from baseline vs 0.6% with placebo) at 68 weeks with improvement in cardiometabolic risk factors (i.e
Essential Bloodwork: To ensure your safety and tailor the program to your needs, we require specific blood tests
Compounding pharmacies work under FDA guidelines to create medications tailored to individual patient needs